Study of Endothelial Cell Condition After Cataract Surgery Performed Using Capsulorhexis or ZEPTO

Inclusion Criteria: * Subjects consenting to undergoing phacoemulsification and IOL implant surgery for the treatment of symptomatic age-related lens cataract, and then electing to undergo the study, * Subjects must be willing and able to return for scheduled treatment and follow-up examinations at 1 and 3 months. Exclusion Criteria: * Pre-existing corneal endothelium pathology * Presence of guttae * Narrow angle glaucoma or advanced glaucoma * Psuedoexfoliation * Zonular abnormalities * Corneal endothelial cell density less than 1800 cells/mm2 * Uveitis * Anterior chamber depth less than 2.5mm or greater than 3.75mm * Cataract grade LOCS II \> 3 * Posterior polar cataract * Planned implantation of IOL \> 25D * Prior ocular surgery in the study eye * History of medications with potential corneal endothelial cell toxicity * Any condition that in the surgeon's judgement should exclude the subject from study enrollment. * Current participation in another drug or device clinical study, or participation in such a clinical study within the prior six months and during the duration of the current study